Mergers

Say goodbye to Tocagen, struggling brain cancer biotech to reverse merge with Forte Biosciences

3 days ago   |   San Diego Biotechnology

Five months after a huge Phase III failure triggered mass layoffs at the company, Tocagen will sign itself out of existence. Paul Wagner The biotech, once focused on brain...
Read more ...

ResTORbio Pins “Strategic Alternatives” Pitch to Parkinson's Promise

ResTORbio Pins “Strategic Alternatives” Pitch to Parkinson's Promise

4 days ago   |   Xconomy

Three months after resTORbio's lead drug failed a pivotal test treating lung infections in the elderly , the company is now looking for someone to buy the firm or strike a deal...
Read more ...

Bio Roundup: Mammoth Moves, Black Diamond's Pop, Ohana's Debut & More

Bio Roundup: Mammoth Moves, Black Diamond's Pop, Ohana's Debut & More

24 days ago   |   Xconomy

If this week is any indication, the steady march of life science companies to Wall Street will continue in 2020. Black Diamond Therapeutics is leading the way, having raised...
Read more ...

Histogen, Timber Pharma Plan Reverse Mergers to Join Public Markets

Histogen, Timber Pharma Plan Reverse Mergers to Join Public Markets

26 days ago   |   Xconomy

Two privately held biotechs on Tuesday announced plans for reverse mergers, transactions that provide a faster route to go public than a conventional IPO and also give...
Read more ...

Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie

Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie

27 days ago   |   Xconomy   |   2 articles

Allergan is selling off an experimental drug and a commercialized product in order to allay antitrust concerns from regulators reviewing the company's $63 billion acquisition...
Read more ...

Allergan axes AstraZeneca deal, clearing path for AbbVie merger

28 days ago   |   Fierce Biotech   |   2 articles

Allergan has terminated a deal with AstraZeneca to clear a regulatory barrier to its pending merger with AbbVie. The terms of the termination return the rights to brazikumab to...
Read more ...

JPM Monday roundup: No deals, but drug-pricing startup causes the biggest noise

1 month ago   |   Fierce Biotech

SAN FRANCISCO-Well, let's start with the obvious, a pattern that has been set for a good few years now: There were no M&A deals on the so-called Merger Monday that typically...
Read more ...

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies to Acquire Leading Oncology Research and Development Company Sapphire Biotech, Inc

1 month ago   |   San Diego Biotechnology   |   5 articles

SAN DIEGO, Jan. 9, 2020 /PRNewswire/ - Medical Marijuana, Inc. , the first-ever publicly traded cannabis company in the United States that launched the world's first-ever...
Read more ...

Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto

Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto

1 month ago   |   Xconomy

When a group of scientists from Amira Pharmaceuticals wanted to start a new biotech after the company's 2011 acquisition by Bristol-Myers Squibb , Celgene provided seed...
Read more ...

After Antitrust Challenges, Illumina and PacBio Throw in Towel on Merger

After Antitrust Challenges, Illumina and PacBio Throw in Towel on Merger

1 month ago   |   Xconomy   |   2 articles

DNA sequencing machine maker Illumina will have to find another way to “read” long pieces of genetic material as well as short stretches, the genomic giant's bailiwick. Its...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Veterinarians have a saying that a cat is not a small dog, says Invetx CEO Juergen Horn. Obviously, a dog of any size isn't the same as a human. But Horn, a veterinarian, says... Read more ...

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

A migraine drug that Lundbeck added to its pipeline via its nearly $2 billion acquisition of Alder BioPharmaceuticals won FDA approval on Friday. The drug, eptinezumab , is... Read more ...

Arima Genomics Completes Series A Financing

SAN DIEGO--Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and... Read more ...

Viking Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, Feb. 24, 2020 /PRNewswire/ - Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and... Read more ...

Molecular characterization and overexpression analyses of secologanin...

Abstract Camptothecin is a high-value anti-cancerous compound produced in many taxonomically unrelated species. Its biosynthesis involves a complex network of pathways and a... Read more ...

Modulation of the Purine Pathway for Riboflavin Production in Flavinogenic...

Riboflavin is an indispensable nutrient for humans and animals, since it is the precursor of the essential coenzymes FMN and FAD, involved in variety of metabolic reactions... Read more ...

A Critical Review of Genome Editing and Synthetic Biology Applications in...

Being the green gold of the future, microalgae and cyanobacteria have recently attracted considerable interest worldwide, for they can be used to produce different kinds of... Read more ...

Biodegradation of penicillin G from industrial bacteria residue by...

An efficient biodegradation-strengthening approach was developed to improve penicillin G degradation from industrial bacterial residue in an expanded bed adsorption bioreactor... Read more ...

More clues for how the monkeyflower got its spots

The monkeyflower, or Mimulus, though possessing a relatively simple genome is able to produce a stunning array of pigmentation patterns. A team of researchers is one step... Read more ...

A deep dive into cellular aging

Scientists have discovered that mitochondria trigger senescence, the sleep-like state of aged cells, through communication with the cell's nucleus -a nd identified an... Read more ...